Theralase Technologies Inc. (TLT)

PRESS RELEASE

published on 10/05/2023 at 13:00, 1 year 7 months ago

Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE

published on 09/29/2023 at 13:00, 1 year 8 months ago

Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE

published on 09/27/2023 at 13:00, 1 year 8 months ago

Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE

published on 09/21/2023 at 22:35, 1 year 8 months ago

Theralase(R) Grants Stock Options
PRESS RELEASE

published on 09/07/2023 at 10:30, 1 year 8 months ago

Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE

published on 08/29/2023 at 22:30, 1 year 9 months ago

Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE

published on 06/30/2023 at 22:35, 1 year 11 months ago

Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE

published on 06/06/2023 at 13:00, 1 year 11 months ago

Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE

published on 05/31/2023 at 03:30, 2 years ago

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE

published on 05/31/2023 at 01:35, 2 years ago

Theralase(R) Releases 1Q2023 Interim Financial Statements

Published on 05/30/2025 at 22:00, 1 day 19 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 1 day 19 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 1 day 23 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 3 days 18 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 3 days 18 hours ago

Engagements collectifs de conservation de titres de la société

News